Literature DB >> 26676363

Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.

Jia Li1, Er-Bao Bian1, Xiao-Jun He1, Chun-Chun Ma1, Gang Zong1, Hong-Liang Wang1, Bing Zhao1.   

Abstract

Epigenetic regulation plays a significant role in gliomas. However, how methylation and long non-coding RNA (lncRNA) cooperates to regulate gliomas progression is largely unknown. In this investigation we showed that the downregulation of MEG3 expression due to hypermethylation of MEG3 was observed in gliomas tissues. Treatment of glioma cells with the DNA methylation inhibitor 5-Aza-2'-deoxycytidine (5-AzadC) decreased aberrant hypermethylation of the MEG3 promoter and prevented the loss of MEG3 expression. In addition, DNMT1 was involved in MEG3 promoter methylation, and was inversely correlated with MEG3 expression in gliomas. The inhibition of DNMT1 repressed the proliferation, clone formation, and induced apoptosis in glioma cells. Importantly, the inhibition of DNMT1 contributed to the activation of p53 pathways in gliomas cells. These results suggest that DNMT1-mediated MEG3 hypermethylation caused the loss of MEG3 expression, followed by the inhibition of the p53 pathways in gliomas.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26676363     DOI: 10.3892/ijo.2015.3285

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  51 in total

1.  LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation.

Authors:  C Zhou; C Huang; J Wang; H Huang; J Li; Q Xie; Y Liu; J Zhu; Y Li; D Zhang; Q Zhu; C Huang
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

Review 2.  LncRNAs: macromolecules with big roles in neurobiology and neurological diseases.

Authors:  Ye Chen; Jun Zhou
Journal:  Metab Brain Dis       Date:  2017-02-04       Impact factor: 3.584

3.  Long non-coding RNA Fer-1-like family member 4 is overexpressed in human glioblastoma and regulates the tumorigenicity of glioma cells.

Authors:  Feng Ding; Hongtu Tang; Dekang Nie; Liang Xia
Journal:  Oncol Lett       Date:  2017-06-16       Impact factor: 2.967

4.  Long non-coding RNA CASC15 promotes tongue squamous carcinoma progression through targeting miR-33a-5p.

Authors:  Zhibin Zuo; Long Ma; Zuode Gong; Lande Xue; Qibao Wang
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-26       Impact factor: 4.223

Review 5.  MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.

Authors:  Arwa Al-Rugeebah; Mohammed Alanazi; Narasimha Reddy Parine
Journal:  Pathol Oncol Res       Date:  2019-02-21       Impact factor: 3.201

6.  [Overexpression of lncRNA MEG3 inhibits proliferation and invasion of glioblastoma U251 cells in vitro by suppressing HIF1α expression].

Authors:  Qizhi Luo; Fan Zhang; Wei Li; Fang Wang; Lixiang Wu; Baisheng Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

Review 7.  A critical overview of long non-coding RNA in glioma etiology 2016: an update.

Authors:  Yuan-Feng Gao; Zhi-Bin Wang; Tao Zhu; Chen-Xue Mao; Xiao-Yuan Mao; Ling Li; Ji-Ye Yin; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2016-09-15

8.  Immunologic and gene expression profiles of spontaneous canine oligodendrogliomas.

Authors:  Anna Filley; Mario Henriquez; Tanmoy Bhowmik; Brij Nath Tewari; Xi Rao; Jun Wan; Margaret A Miller; Yunlong Liu; R Timothy Bentley; Mahua Dey
Journal:  J Neurooncol       Date:  2018-01-12       Impact factor: 4.130

9.  Promoter hypermethylation influences the suppressive role of long non-coding RNA MEG3 in the development of multiple myeloma.

Authors:  Wenjun Yu; Qinglin Shi; Chao Wu; Xuxing Shen; Lijuan Chen; Jiaren Xu
Journal:  Exp Ther Med       Date:  2020-05-06       Impact factor: 2.447

10.  Curcumin suppresses tumor growth of gemcitabine-resistant non-small cell lung cancer by regulating lncRNA-MEG3 and PTEN signaling.

Authors:  L Gao; T Shao; W Zheng; J Ding
Journal:  Clin Transl Oncol       Date:  2021-02-10       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.